Circular Genomics Announces Launch of MindLight, the 1st SSRI Antidepressant Response Test Using Brain-Derived Biomarkers

MindLight is the first circular RNA biomarker-based assay designed to predict whether a patient with depression, also known as major depressive disorder, will respond to selective serotonin reuptake inhibitor (SSRI) antidepressant treatment.